BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 14534297)

  • 1. Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.
    Joerger AC; Allen MD; Fersht AR
    J Biol Chem; 2004 Jan; 279(2):1291-6. PubMed ID: 14534297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.
    Wallentine BD; Wang Y; Tretyachenko-Ladokhina V; Tan M; Senear DF; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2146-56. PubMed ID: 24100332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Cho Y; Gorina S; Jeffrey PD; Pavletich NP
    Science; 1994 Jul; 265(5170):346-55. PubMed ID: 8023157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the quest for stable rescuing mutants of p53: computational mutagenesis of flexible loop L1.
    Pan Y; Ma B; Venkataraghavan RB; Levine AJ; Nussinov R
    Biochemistry; 2005 Feb; 44(5):1423-32. PubMed ID: 15683227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.
    Gorina S; Pavletich NP
    Science; 1996 Nov; 274(5289):1001-5. PubMed ID: 8875926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.
    Joerger AC; Ang HC; Veprintsev DB; Blair CM; Fersht AR
    J Biol Chem; 2005 Apr; 280(16):16030-7. PubMed ID: 15703170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.
    Nikolova PV; Wong KB; DeDecker B; Henckel J; Fersht AR
    EMBO J; 2000 Feb; 19(3):370-8. PubMed ID: 10654936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot-spot mutants of p53 core domain evince characteristic local structural changes.
    Wong KB; DeDecker BS; Freund SM; Proctor MR; Bycroft M; Fersht AR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8438-42. PubMed ID: 10411893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability.
    Nikolova PV; Henckel J; Lane DP; Fersht AR
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14675-80. PubMed ID: 9843948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the mouse p53 core DNA-binding domain at 2.7 A resolution.
    Zhao K; Chai X; Johnston K; Clements A; Marmorstein R
    J Biol Chem; 2001 Apr; 276(15):12120-7. PubMed ID: 11152481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
    Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
    J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain.
    Calhoun S; Daggett V
    Biochemistry; 2011 Jun; 50(23):5345-53. PubMed ID: 21561095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural biology of the tumor suppressor p53 and cancer-associated mutants.
    Joerger AC; Fersht AR
    Adv Cancer Res; 2007; 97():1-23. PubMed ID: 17419939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds.
    Ho WC; Luo C; Zhao K; Chai X; Fitzgerald MX; Marmorstein R
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1484-93. PubMed ID: 17139084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro structure-function analysis of the beta-strand 326-333 of human p53.
    Chène P; Mittl P; Grütter M
    J Mol Biol; 1997 Nov; 273(4):873-81. PubMed ID: 9367778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic mutations and packing defects in protein structure.
    Fernández A
    J Biomol Struct Dyn; 2003 Aug; 21(1):9-14. PubMed ID: 12854955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution.
    Tu C; Tan YH; Shaw G; Zhou Z; Bai Y; Luo R; Ji X
    Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):471-7. PubMed ID: 18453682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain.
    Wright JD; Noskov SY; Lim C
    Nucleic Acids Res; 2002 Apr; 30(7):1563-74. PubMed ID: 11917017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding.
    Gomes AS; Trovão F; Andrade Pinheiro B; Freire F; Gomes S; Oliveira C; Domingues L; Romão MJ; Saraiva L; Carvalho AL
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.